Observer based nonlinear control design for glucose regulation in type 1 diabetic patients: An LMI approach

https://doi.org/10.1016/j.bspc.2018.07.020Get rights and content

Abstract

This paper deals with the design of observer-based nonlinear control of blood glucose concentration (BGC) of Type 1 diabetes mellitus (T1DM) patients in a Linear Matrix Inequality (LMI) framework. The controller design relies on the information of the states obtained from a nonlinear observer. The control law is derived using feedback linearisation and regional pole placement technique. Further, a numerical optimisation method is proposed for the computation of the controller gains by capturing the relationship between transformed domain and original domain dynamics by iteratively tuning the circular LMI region parameters (‘q’ and ‘r’) such that the locations of closed-loop poles of the original nonlinear system are attained. The proposed controller can deliver robust closed-loop response of BGC within a specified range of parametric uncertainty and meal disturbances owing to the appropriately tuned bound of LMI region parameters. The performance of the proposed controller is tested for 100 virtual T1DM patients in the presence of parametric uncertainty and uncertain meal disturbance. Both severe hypoglycemia (<50 mg/dl) and post-prandial hyperglycemia are avoided by the proposed scheme for nominal and uncertain parameters.

Introduction

The endocrine hormone, insulin is the primary regulator of blood glucose concentration (BGC) in the human body. Type 1 diabetes mellitus (T1DM) is a chronic disease characterised by prolonged elevated BGC due to negligible insulin production by the pancreatic β-cells [1]. It is one of the leading cause of deaths around the world that accounted for about 1.5 million deaths in 2012 [2]. The regulation of BGC in the safe range (70–180 mg/dl) is a major problem in T1DM [1]. If the BGC following a meal for an individual does not return to the basal value within 180 min, then this situation is termed as post-prandial hyperglycemia [3]. Hyperglycemia (BGC > 180 mg/dl) is associated with long-term health complications that include cardiac arrests, cerebral stroke, renal failure, loss of vision, diabetes ketoacidosis, etc. Similarly, severe hypoglycemia (BGC < 50 mg/dl) leads to a serious immediate effect that may lead to diabetic coma [4]. In order to minimise the risks associated with improper dosing of external insulin, fully automated system called Artificial Pancreas system (APS) comprising of continuous glucose monitoring (CGM) devices (for glucose measurement), continuous insulin infusion pumps (for exogenous insulin infusion) and closed loop control algorithm (for computing and adjusting the insulin dosages) has evolved successfully in the last few decades [5], [6]. The physiological parameters such as insulin sensitivity, time-to-peak in BGC following a meal and the parameters related to insulin absorption vary significantly within a population of T1DM patients in a physiologically plausible range. This is termed as inter-patient variability and it is one of the major hindrances to the blood glucose regulation in T1DM patients [7].

The primary objective of the current work is to design a closed loop control algorithm that will regulate the plasma glucose concentration within the safe range (70–180 mg/dl) in the presence of uncertain meal disturbances and parametric uncertainty representing the inter-patient variability of T1DM patients.

The basis of the model-based control algorithms are the physiological models that differ in their structures and degrees of complexity in describing the glucose-insulin regulatory system of T1DM patients [6]. Physiological T1DM models can be broadly categorised into two categories: (i) IVGTT (Intravenous Glucose Tolerance Test) models where both the glucose measurements and insulin infusions are done intravenously, and (ii) subcutaneous models include subcutaneous glucose measurements and subcutaneous insulin infusions [8]. This paper deals with the design of appropriate controller based on nonlinear IVGTT Bergman's minimal model (BMM) [8]. BMM provides a very good trade-off between the model complexity and the nonlinear characteristics of the glucose-insulin regulatory system. The more complicated physiological models like the Sorensen's model [9], the Hovorka's model [10] or the Dalla Man's model [11] pose a great challenge to the control engineers in designing appropriate control laws due to the existence of a large number of state variables as well as highly complex nonlinear functions. IVGTT models find important applications for the regulation of BGC in intensive care unit (ICU) patients and for treating diabetes ketoacidosis [12].

In the last four decades, numerous control algorithms based on both linear and nonlinear models have been proposed for the blood glucose regulation of T1DM patients. Conventional PID control schemes were developed as reported in [13], while robust and adaptive control algorithms were also reported in [14]. Due to the constraint handling capability and optimal control feature, model predictive controllers are the most popular control algorithms that are incorporated in the APS [15]. Apart from the conventional control algorithms, intelligent control schemes like fuzzy logic control [16] and neural network control [17] are also designed and some of them are implemented practically. The literature reveals that a vast majority of control algorithms are either based on linearised version of the nonlinear physiological model or time-series model. The linearisation of the original nonlinear system result in significant loss of the nonlinear characteristics of the system resulting in the deterioration of the control performance at operating points other than the equilibrium point. The major difficulty with the time-series models is that it becomes difficult to express important physiological factors in terms of the model parameters directly [18]. Further, the model-based control algorithms explicitly uses the information of all the state variables (related to both blood glucose and insulin), but the measurement of all states are not practically possible in APS because of high cost and reliability issues [8], [19]. Also, the computational aspect of nonlinear control technique is another point of concern.

Thus, the main motivations behind the proposed work are to first design a nonlinear controller that utilises BGC information only. Secondly, the computational aspect of the controller gain should be simple, efficient yet robust enough.

The paper is organised into seven sections. The related works are discussed in Section 2. Section 3 clearly states the problem formulation. The mathematical model and the observer-based controller design are presented in Section 4. While Section 5 presents the simulation results, Section 6 provides the detailed analysis of the simulation experiments. Finally, the concluding remarks and the future scopes are provided in Section 7.

Section snippets

Related work and contributions

In [20] observer-based feedback linearisation for the nonlinear time-delay T1DM model were designed. Model predictive controllers (MPC) based on conventional Luenberger observer theory for linear T1DM models were proposed in [21]. In [22] a Luenberger observer for a linearised version of BMM was proposed for a single T1DM patient without considering any parametric variations. Although important works in observer design for BMM include the design of unscented Kalman filter in [23] and extended

Problem formulation

In this section the genesis of the problem formulation is presented briefly. Referring to Fig. 1, it is obvious that present work considers a nonlinear model of the T1DM patient with only BGC as the measurable state. Utilising the estimated states, a nonlinear control law is derived where the controller gain matrix is selected through the regional pole-placement technique.

Proposed method

In this section discussion pertaining to the state space representation of the considered nonlinear model of a T1DM patient for regulator problem as well as the observer-based controller design via feedback-linearisation and regional placement are presented.

Simulation results

In this section, two simulation scenarios are considered in order to evaluate the performance of the proposed nonlinear observer based control technique in regulating BGC of T1DM subjects within the safe range (70–180 mg/dl). While scenario #1 deals with the effect of high meal content, scenario 2 accounts for the glucose variability due to random parameters and random exogenous meal disturbance. For both of these scenarios, the parameter p1 representing the glucose effectiveness is assumed to

Discussions

The BGC is brought from an initial hyperglycemic state (260 mg/dl) to the basal value (Gb) within 300 min without any instances of severe hypoglycemia (<50 mg/dl). Postprandial hyperglycemia is avoided by bringing BGC below 180 mg/dl within 150 min in the presence of high meal disturbance of 10 mg/dl/min as depicted in Fig. 5. The external insulin infusion rate (control signal, u(t)) is a smooth (non-aggressive) signal with a negative slope as illustrated in Fig. 6. It can be inferred from Fig.

Conclusions

This work presents a simple yet novel observer based nonlinear controller strategy for the control of blood glucose concentration of IVGTT patient model. Both the observer and controller are designed for the first time in an LMI framework for the considered model. The proposed controller design is novel due to its simplicity in numerical computation and further computing the gain matrix K by capturing the relationship between the transformed domain dynamics and original dynamics via proposed

References (53)

  • E. Ruiz-Velázquez et al.

    Blood glucose control for type I diabetes mellitus: a robust tracking h8 problem

    Control Eng. Pract.

    (2004)
  • L. Kovács

    Linear parameter varying (LPV) based robust control of type-I diabetes driven for real patient data

    Knowl.-Based Syst.

    (2017)
  • B.W. Bequette et al.

    Overnight hypoglycemia and hyperglycemia mitigation for individuals with type 1 diabetes: how risks can be reduced

    IEEE Control Syst.

    (2018)
  • World Health Organization

    Global Report on Diabetes

    (2016)
  • S.K. Singh

    Post-prandial hyperglycemia

    Indian J. Endocrinol. Metab.

    (2012)
  • A. El Fathi et al.

    The artificial pancreas and meal control: an overview of postprandial glucose regulation in type 1 diabetes

    IEEE Control Syst.

    (2018)
  • L.M. Huyett et al.

    Glucose sensor dynamics and the artificial pancreas: the impact of lag on sensor measurement and controller performance

    IEEE Control Syst.

    (2018)
  • A. Haidar

    The artificial pancreas: how closed-loop control is revolutionizing diabetes

    IEEE Control Syst.

    (2016)
  • J. Bondia et al.

    Insulin estimation and prediction: a review of the estimation and prediction of subcutaneous insulin pharmacokinetics in closed-loop glucose control

    IEEE Control Syst.

    (2018)
  • Z. Benyó et al.

    Model-based Nonlinear Optimal Blood Glucose Control of Type I Diabetes Patients

    (2008)
  • R. Hovorka et al.

    Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes

    Physiol. Meas.

    (2004)
  • C. Dalla Man et al.

    Meal simulation model of the glucose–insulin system

    IEEE Trans. Biomed. Eng.

    (2007)
  • A. Nath et al.

    Blood glucose regulation in type 1 diabetic patients: an adaptive parametric compensation control based approach

    IET Syst. Biol.

    (2018)
  • S.A. Weinzimer et al.

    Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

    Diabetes Care

    (2008)
  • F.H. El-Khatib et al.

    A bihormonal closed-loop artificial pancreas for type 1 diabetes

    Sci. Transl. Med.

    (2010)
  • A. Nath et al.

    Closed loop blood glucose regulation of type 1 diabetic patient using Takagi-Sugeno fuzzy logic control

    International Workshop Soft Computing Applications

    (2016)
  • Cited by (0)

    View full text